TRAF6 Polyclonal Antibody

TNF receptor-associated factor 6 encoded by TRAF6 is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain. Two alternatively spliced transcript variants, encoding an identical protein, have been reported.

The TRAF6 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of TRAF6 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards TRAF6.

TRAF6, also known as TNF receptor-associated factor 6, is a crucial signaling molecule involved in multiple cellular processes, including immune response, inflammation, and bone metabolism. Dysregulation of TRAF6 has been implicated in various diseases, such as autoimmune disorders, cancer, and osteoporosis.

The TRAF6 Polyclonal Antibody exhibits exceptional performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of TRAF6 protein in a wide range of species, making it a versatile tool for researchers working with different model organisms.

With its high sensitivity and specificity, this antibody enables accurate and reliable detection of TRAF6 protein expression, facilitating in-depth investigations into its functional roles and molecular mechanisms. Its robust performance ensures reproducible results, making it an ideal choice for both basic research and clinical studies.

The TRAF6 Polyclonal Antibody is supplied in a convenient and ready-to-use format, allowing for easy integration into laboratory workflows. It is provided in a liquid formulation, ensuring stability and ease of handling. Each batch of antibody undergoes rigorous quality control tests to guarantee consistent performance and lot-to-lot reproducibility.

In summary, the TRAF6 Polyclonal Antibody is a valuable tool for researchers seeking to explore the intricate functions of TRAF6 protein. Its high specificity, sensitivity, and versatility make it an indispensable asset in various research areas, including immunology, oncology, and bone biology.